Founded in 2003, ABL - Antibiotics do Brasil joined ACS Dobfar, an Italian group with more than 40 years of existence, one of the world leaders in the manufacture and commercialization of antibiotics (raw materials and finished products). In 2011, ACS Dobfar acquired Beker, a company active in the Brazilian market for more than 30 years, producing parenteral solutions, started to complement the ABL product line. ABL stands out as one of the leading companies in the hospital segment, with a diversified line of medicines (Reference, Similar and Generic) among which are renowned products such as Keflin, Kefazole, Dobutrex, Vancocina, Tobramine. Headquartered in São Paulo, the capital city of ABL is located in Cosmopolis, São Paulo, and is the only company in Latin America to have international approvals for the production of cephalosporins for the USA, Europe and Japan